The paper on “Risk Management Strategies for Biotech Startups” explores the complex difficulties encountered by nascent biotechnology companies, due to their substantial expenses in experimental research and development, financial limitations, and ever-changing market circumstances. The research used thematic analysis to examine a comprehensive risk management framework. This analysis is conducted utilizing secondary data obtained from literature and research sources. The identified themes include the Risk Profile Concept, which explores the genetic intricacies and dangers faced by biotech companies, the Impact of Risk on startups in relation to regulatory obstacles and economic instability, and the Risk Reduction Schedule, which outlines systematic methods to minimize environmental, procedural, and industrial risks. The study delves into Financial Risk Mitigation, with a focus on strategic financial management to achieve sustainable growth. It also examines Operational Impact and Risk Control, which deals with the complexities of operations and challenges related to compliance. Furthermore, it discusses Strategic Risk Assessment, which highlights the importance of aligning strategic goals with risk management. The methodology entails doing a qualitative thematic analysis of the current literature, which enables a comprehensive comprehension of risk management in the biotechnology industry. The findings support the development of robust startups that are capable of navigating the complex biotechnology sector and positioning themselves for global competitiveness. © 2024 selection and editorial matter, Prof. (Dr.) Dorota Jelonek, Prof. (Dr.) Narendra Kumar, Prof. (Dr.) Mamta Chahar, Prof. (Dr.) Rusudan Kinkladze and Prof. (Dr.) Lilla Knop; individual chapters, the contributors.